CDKN2B and cancer: In this single-center study, we identify common genomic alterations in several genes across cancer types including TP53 (64% of specimens), CDKN2A (37%), TERT (29%), CDKN2B (23%), NF1 (14%), KRAS (14%), and PTEN (13%).